# SOX1

## Overview
SOX1 is a gene that encodes the SRY-box transcription factor 1, a member of the SOXB1 subgroup of transcription factors, which also includes SOX2 and SOX3. This protein is characterized by a conserved high-mobility group (HMG) box domain, which facilitates its role as a transcriptional activator by binding to DNA. SOX1 is primarily involved in the development and maintenance of the nervous system, playing a crucial role in the identity and survival of neural stem/progenitor cells during embryogenesis. It is expressed early in the neuroectoderm, marking the commitment of ectodermal cells to a neural fate. Beyond its developmental functions, SOX1 also interacts with key signaling pathways, such as the Wnt/β-catenin pathway, and acts as a tumor suppressor in various cancers, where its expression is often down-regulated through epigenetic modifications like promoter hypermethylation (Guan2014SOX1; Pevny2005SOX; Kanwore2021SOX1).

## Structure
The SOX1 protein is a transcription factor characterized by a conserved high-mobility group (HMG) box domain, which is a well-defined DNA-binding domain consisting of three conserved α-helices (Ahmad2020In; Kiefer2007Back). The primary structure of SOX1 includes specific sequences that undergo post-translational modifications (PTMs) such as phosphorylation, acetylation, glycosylation, and sumoylation, which are crucial for its function (Ahmad2020In). Phosphorylation at serine residues S93 and S325, for example, is significant for DNA binding and transcription factor activities (Ahmad2020In). 

The tertiary structure of SOX1, analyzed using I-TASSER, reveals three folded domains: the HMG Box (residues 49-120), the SOXp domain (residues 129-194), and the C-terminal domain (residues 263-366), separated by disordered sequences (Ahmad2020In). These domains are involved in DNA binding and interactions with partner proteins, with PTMs like acetylation and sumoylation potentially influencing these interactions (Ahmad2020In). The SOXB1 consensus motif, xKSExSxxP, is a notable feature within the protein, shared with other transcription factors in the SOXB1 sub-family (Ahmad2020In). The presence of splice variant isoforms is not detailed in the provided context.

## Function
SOX1 is a transcription factor that plays a critical role in the development and maintenance of the nervous system. It is part of the SOXB1 subgroup, which includes SOX2 and SOX3, and is characterized by a high degree of amino acid identity in their HMG-DNA binding domain, essential for their function as transcriptional activators (Pevny2005SOX). SOX1 is primarily expressed in the neuroectoderm and is involved in maintaining the identity of neural stem/progenitor cells during embryogenesis (Feng2014Generation). It is one of the earliest transcription factors expressed in ectodermal cells committed to a neural fate, marking the induction of neural ectoderm (Pevny2005SOX).

SOX1 is crucial for the survival and proper functioning of dopaminergic neurons, which are vital for brain function (Kanwore2021SOX1). It interacts with other genes, such as GDNF, to regulate neural stem cell survival and differentiation (Kanwore2021SOX1). The gene's expression is modulated by epigenetic changes, such as methylation and acetylation, affecting its role in neural and cancer stem cell proliferation (Kanwore2021SOX1). SOX1's activity is primarily nuclear, where it binds to DNA to regulate gene expression, ensuring the maintenance of neural progenitor identity and inhibiting premature neuronal differentiation (Pevny2005SOX).

## Clinical Significance
Alterations in the expression of the SOX1 gene have been implicated in various cancers. In nasopharyngeal carcinoma (NPC), SOX1 is frequently down-regulated due to promoter hypermethylation, which contributes to the malignant phenotype of the cancer. The down-regulation of SOX1 leads to increased activity of the Wnt/β-catenin signaling pathway, promoting tumorigenesis. Restoring SOX1 expression in NPC cells has been shown to suppress tumor growth, reduce cell migration, and reverse epithelial-mesenchymal transition (Guan2014SOX1).

In esophageal squamous cell carcinoma (ESCC), decreased SOX1 expression is associated with poor prognosis indicators such as advanced tumor stages and lymph node metastasis. The down-regulation of SOX1 in ESCC is linked to the overexpression of cancer stem cell markers like SALL4, suggesting a role in tumor progression and invasiveness (Rad2016SOX1). Hypermethylation of the SOX1 promoter is also observed in ESCC, where it serves as a potential biomarker for early detection (Tang2019Aberrant).

SOX1 hypermethylation has been identified in other cancers, including colorectal cancer, where it is associated with advanced disease stages. This epigenetic alteration is a common mechanism for silencing tumor suppressor genes like SOX1 in various carcinomas (Huang2017DNA).

## Interactions
SOX1, a transcription factor, is known to interact with β-catenin, a key component of the Wnt signaling pathway. This interaction is crucial in modulating the Wnt/β-catenin signaling pathway, which is involved in various cellular processes, including cell proliferation and differentiation. SOX1 physically binds to β-catenin, leading to its down-regulation in a proteasome-independent manner, thereby inhibiting β-catenin-mediated TCF/LEF signaling. This interaction results in the suppression of downstream target genes such as Cyclin D1 and c-Myc, while up-regulating cell cycle inhibitors like p21 and p27 (Guan2014SOX1).

SOX1's interaction with β-catenin is significant in reversing the malignant phenotype in nasopharyngeal carcinoma (NPC) cells, as it reduces cell proliferation, migration, and epithelial-mesenchymal transition (EMT), while promoting cell differentiation and senescence (Guan2014SOX1). The binding of SOX1 to β-catenin also suggests a competitive interaction with TCF factors for β-catenin binding, which can modulate the transcriptional activity of Wnt-target genes (Kormish2009Interactions). These interactions highlight SOX1's role as a tumor suppressor and its potential therapeutic implications in cancer treatment.


## References


[1. (Guan2014SOX1) Zhong Guan, Jialiang Zhang, Jing Wang, Hefei Wang, Feimeng Zheng, Jieren Peng, Yaodong Xu, Min Yan, Bing Liu, Bai Cui, Ying Huang, and Quentin Liu. Sox1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma. Molecular Cancer, November 2014. URL: http://dx.doi.org/10.1186/1476-4598-13-257, doi:10.1186/1476-4598-13-257. This article has 42 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-13-257)

[2. (Feng2014Generation) Nianhua Feng, Qin Han, Jing Li, Shihua Wang, Hongling Li, Xinglei Yao, and Robert Chunhua Zhao. Generation of highly purified neural stem cells from human adipose-derived mesenchymal stem cells bysox1activation. Stem Cells and Development, 23(5):515–529, March 2014. URL: http://dx.doi.org/10.1089/scd.2013.0263, doi:10.1089/scd.2013.0263. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/scd.2013.0263)

[3. (Rad2016SOX1) Abolfazl Rad, Saeed Esmaeili Dizghandi, Mohammad Reza Abbaszadegan, Negin Taghechian, Maryam Najafi, and Mohammad Mahdi Forghanifard. Sox1 is correlated to stemness state regulator sall4 through progression and invasiveness of esophageal squamous cell carcinoma. Gene, 594(2):171–175, December 2016. URL: http://dx.doi.org/10.1016/j.gene.2016.08.045, doi:10.1016/j.gene.2016.08.045. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2016.08.045)

[4. (Tang2019Aberrant) Li Tang, Yu-Ligh Liou, Zi-Rui Wan, Jie Tang, Yuan Zhou, Wei Zhuang, and Guo Wang. Aberrant dna methylation of pax1, sox1 and znf582 genes as potential biomarkers for esophageal squamous cell carcinoma. Biomedicine &amp; Pharmacotherapy, 120:109488, December 2019. URL: http://dx.doi.org/10.1016/j.biopha.2019.109488, doi:10.1016/j.biopha.2019.109488. This article has 30 citations.](https://doi.org/10.1016/j.biopha.2019.109488)

[5. (Kormish2009Interactions) Jay D. Kormish, Débora Sinner, and Aaron M. Zorn. Interactions between sox factors and wnt/β‐catenin signaling in development and disease. Developmental Dynamics, 239(1):56–68, August 2009. URL: http://dx.doi.org/10.1002/dvdy.22046, doi:10.1002/dvdy.22046. This article has 184 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.22046)

[6. (Huang2017DNA) Jin Huang, Zhi-Rong Tan, Jing Yu, He Li, Qiao-Li Lv, Ying-Ying Shao, and Hong-Hao Zhou. Dna hypermethylated status and gene expression of &lt;em&gt;pax1/sox1&lt;/em&gt; in patients with colorectal carcinoma. OncoTargets and Therapy, Volume 10:4739–4751, September 2017. URL: http://dx.doi.org/10.2147/OTT.S143389, doi:10.2147/ott.s143389. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/OTT.S143389)

[7. (Ahmad2020In) Azaz Ahmad, Stephanie Strohbuecker, Claudia Scotti, Cristina Tufarelli, and Virginie Sottile. In silico identification of sox1 post-translational modifications highlights a shared protein motif. Cells, 9(11):2471, November 2020. URL: http://dx.doi.org/10.3390/cells9112471, doi:10.3390/cells9112471. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9112471)

[8. (Kiefer2007Back) Julie C. Kiefer. Back to basics: sox genes. Developmental Dynamics, 236(8):2356–2366, June 2007. URL: http://dx.doi.org/10.1002/dvdy.21218, doi:10.1002/dvdy.21218. This article has 168 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.21218)

[9. (Pevny2005SOX) Larysa Pevny and Marysia Placzek. Sox genes and neural progenitor identity. Current Opinion in Neurobiology, 15(1):7–13, February 2005. URL: http://dx.doi.org/10.1016/j.conb.2005.01.016, doi:10.1016/j.conb.2005.01.016. This article has 235 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.conb.2005.01.016)

[10. (Kanwore2021SOX1) Kouminin Kanwore, Xiao-xiao Guo, Ayanlaja Abiola Abdulrahman, Piniel Alphayo Kambey, Iqra Nadeem, and Dianshuai Gao. Sox1 is a backup gene for brain neurons and glioma stem cell protection and proliferation. Molecular Neurobiology, 58(6):2634–2642, January 2021. URL: http://dx.doi.org/10.1007/s12035-020-02240-6, doi:10.1007/s12035-020-02240-6. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-020-02240-6)